This commentary, published in Nature Medicine, reviews current trends that may affect whether the most promising of the 350 vaccine candidates under development will eventually be used in programs for the poor in developing countries. It also discusses how the generation of evidence has become an increasingly important determinant of vaccine introduction.

Author(s): Clemens J, Jodar L

Published: 2005

Resource types: Peer-reviewed journal

Diseases: Haemophilus influenzae type b (Hib); Hepatitis B; Japanese encephalitis; Malaria; Meningococcus; Pneumococcus; Shigellosis and enterotoxigenic Escherichia coli (ETEC); Rotavirus

Topics: Disease/vaccine specific information

Regions: Global